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Abstract
Background: The South African Government has outlined detailed plans for antiretroviral (ART)
rollout in KwaZulu-Natal Province, but has not created a plan to address treatment accessibility in
rural areas in KwaZulu-Natal. Here, we calculate the distance that People Living With HIV/AIDS
(PLWHA) in rural areas in KwaZulu-Natal would have to travel to receive ART. Specifically, we
address the health policy question 'How far will we need to go to reach PLWHA in rural KwaZulu-
Natal?'.
Methods: We developed a model to quantify treatment accessibility in rural areas; the model
incorporates heterogeneity in spatial location of HCFs and patient population. We defined
treatment accessibility in terms of the number of PLWHA that have access to an HCF. We
modeled the treatment-accessibility region (i.e. catchment area) around an HCF by using a two-
dimensional function, and assumed that treatment accessibility decreases as distance from an HCF
increases. Specifically, we used a distance-discounting measure of ART accessibility based upon a
modified form of a two-dimensional gravity-type model. We calculated the effect on treatment
accessibility of: (1) distance from an HCF, and (2) the number of HCFs.
Results: In rural areas in KwaZulu-Natal even substantially increasing the size of a small catchment
area (e.g. from 1 km to 20 km) around an HCF would have a negligible impact (~2%) on increasing
treatment accessibility. The percentage of PLWHA who can receive ART in rural areas in this
province could be as low as ~16%. Even if individuals were willing (and able) to travel 50 km to
receive ART, only ~50% of those in need would be able to access treatment. Surprisingly, we show
that increasing the number of available HCFs for ART distribution ~ threefold does not lead to a
threefold increase in treatment accessibility in rural KwaZulu-Natal.
Conclusion: Our results show that many PLWHA in rural KwaZulu-Natal are unlikely to have
access to ART, and that the impact of an additional 37 HCFs on treatment accessibility in rural
areas would be less substantial than might be expected. There is a great length to go before we will
be able to reach many PLWHA in rural areas in South Africa, and specifically in KwaZulu-Natal.
Published: 19 June 2007
BMC Medicine 2007, 5:16 doi:10.1186/1741-7015-5-16
Received: 10 January 2007
Accepted: 19 June 2007
This article is available from: http://www.biomedcentral.com/1741-7015/5/16
© 2007 Wilson and Blower; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Medicine 2007, 5:16 http://www.biomedcentral.com/1741-7015/5/16
Page 2 of 5
(page number not for citation purposes)
Background
Accessibility to all types of healthcare is generally inade-
quate in rural settings of resource-constrained countries
[1]. Antiretroviral therapies (ART) are still unattainable
for most HIV-infected individuals in these countries,
mainly due to the scarcity of drugs [1]. One of the greatest
remaining obstacles to receiving treatment in rural areas
in these countries is scarcity in health care facilities
(HCFs) [1,2]. Considerable discussion has surrounded
the many logistical and clinical management difficulties
associated with the rollout of ART in Africa [1,3,4]. How-
ever, the travel distances required for many people living
with HIV/AIDS (PLWHA) in rural areas in Africa to reach
an HCF have not yet received much attention. This is the
topic of the present work. We address the health policy
question 'How far will we need to go to reach PLWHA in
rural South Africa?', and specifically, we calculate the dis-
tance that PLWHA who live in rural areas in KwaZulu-
Natal, South Africa, would have to travel to receive treat-
ment.
Implementing HIV/AIDS treatment programs in rural
regions of resource-constrained countries is a realistic goal
as several pilot programs have shown [1-5]. In rural Haiti,
the HIV Equity Initiative (with Partners in Health [4]) has
been extremely effective in introducing and implementing
ART [1,2]. The base clinical facility of this program in
Cange was set-up in a province with no electricity and lim-
ited road access. Trained health workers carry out admin-
istration of ART and follow-up despite large distances
between the primary health care facility and the many
patients needing ART (>5 h by foot for some). Medecins
sans Frontieres has assisted in setting up effective clinics in
semi-rural regions of South Africa (Lusikisiki in the East-
ern Cape [6] and also Khayelitsha in the Western Cape
[3]), and similar programs have been successful in Nigeria
[1]. UNAIDS has also launched pilot projects to improve
ART access in Uganda, Cote d'Ivoire, Chile, and Vietnam
[5] (see [7-9] for other recent reviews of the progress in
resource-constrained settings).
In rural South Africa there is an overall lack of health care
infrastructure, reliable statistics and adequate resources
[10]. This greatly hinders the administration and monitor-
ing of ART. The vast majority of PLWHA are referred to ter-
tiary hospitals and then to district hospitals, requiring
great travel distances [11]. However, various 'residential'
clinics, mobile clinics and community health worker sta-
tions have recently been established in some rural regions
for basic health and ART care. Most notable is the MSF
clinic in Lusikisiki and also a rural, clinic-based antiretro-
viral drug treatment program piloted in the Mseleni dis-
trict of northern KwaZulu-Natal [11].
For most PLWHA living in rural areas who do not have
local clinic-based ART programs, the maximum distance
that they would be able (or willing) to travel for ART is not
clear, but it is the primary determinant of health service
utilization [12]. Road and public transport networks, geo-
graphical barriers, and other factors are also important in
determining treatment accessibility. Here, we develop a
mathematical model, based upon some simplifying
assumptions, that we use to quantify treatment accessibil-
ity in rural areas in KwaZulu-Natal in terms of the number
of PLWHA that have access to ART.
Methods
The South African government has outlined detailed oper-
ational plans [13] for ART rollout in KwaZulu-Natal that
specifies the utilization of 17 currently available HCFs.
The spatial location of these 17 HCFs, and the distribution
of rural communities with populations of 500–100000 is
shown in the map of KwaZulu-Natal in Figure 1a. The 17
HCFs that are specified are a subset of the provincial hos-
pitals of KwaZulu-Natal and do not include community
health centers, residential or mobile clinics, or the rest of
the centers in the primary health care system. We devel-
oped a model to quantify treatment accessibility; the
model incorporates heterogeneity in the spatial location
of both HCFs and patient population. We modeled the
treatment-accessibility region (i.e. the catchment area)
around an HCF by using a two-dimensional function (see
Figure 1b). We calculated the effect on treatment accessi-
bility of: (1) distance from an HCF (i.e. we vary the radius
of the catchment area), and (2) the number of HCFs (the
South African Government currently uses 17 HCFs, but at
least 54 HCFs are available). We defined treatment acces-
sibility in terms of the number of PLWHA that have access
to ART dispensed at an HCF.
To quantify treatment accessibility, we first determined
the total number of PLWHA that live in a catchment area
of a specific size around each of the HCF (i.e. the
'demand'). We then calculated the 'effective demand' by
weighting the 'demand' according to the distance that
PLWHA that reside in the catchment area have to travel to
reach the HCF. We assumed that accessibility to ART
decreases as the distance from the HCF increases; there-
fore we calculated the 'effective demand' around each
HCF by using a distance-discounting measure of ART
accessibility based upon a modified form of a gravity-type
model [14-16]. Similar functions have been used in infec-
tious disease modeling, specifically to model disease
spread [17,18].
To specify our gravity-type model, we used a Gaussian dis-
tribution function: f(d) = exp (-kd2), where d is distance
and k is an access-scaling parameter that quantifies treat-
ment accessibility. The access-scaling parameter is used toBMC Medicine 2007, 5:16 http://www.biomedcentral.com/1741-7015/5/16
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delineate the circumference of the catchment area; 'k' is
defined such that accessibility at the circumference is only
1% of accessibility at the HCF. We used this Gaussian dis-
tribution function to calculate the probability that a
PLWHA at any given distance from the HCF has access to
ART relative to a PLWHA living extremely close to the
HCF. The total number of PLWHA in any rural commu-
nity i that has access to any of the (n)available HCFs is
then calculated by  , where di,j specifies the dis-
tance between the rural community i and the specified
HCF j, and Ii specifies the number of PLWHA in commu-
nity i (estimated from population levels and published
HIV prevalence data of ~9% throughout rural areas [19]).
Results
Our calculations show that in rural areas of KwaZulu-
Natal, there is a nonlinear relationship between treatment
accessibility (i.e. the percentage of PLWHA with access to
ART) and the size of the catchment area. This nonlinear
relationship is most apparent if 17 HCFS are used, but is
also evident if all 54 HCFS are used (Figure 2). In rural
areas in KwaZulu-Natal, even substantially increasing the
size of a small catchment area (e.g. from 1 km to 20 km)
would have a negligible impact on increasing treatment
accessibility (i.e. it would only increase by ~2%); whereas
increasing the size of a large catchment area could signifi-
cantly increase treatment accessibility (Figure 2).
Substantially increasing the size of small catchment areas
around HCFs in rural areas is unlikely to 'capture' a much
larger population of PLWHA, because of the large dis-
tances between rural communities. Catchment areas
around HCFs in KwaZulu-Natal could be as small as 5 km
(Professor Robin Wood, University of Cape Town, per-
sonal communication). Thus the percentage of PLWHA
who can receive ART in rural areas in this province, if 17
HCFs are used, could be as low as ~16% (~18000/
110000) (Figure 2). Even if individuals were willing (and
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The estimated percentage of PLWHA living in rural areas  with access to treatment as a function of the size of the  catchment area radius around each HCF Figure 2
The estimated percentage of PLWHA living in rural areas 
with access to treatment as a function of the size of the 
catchment area radius around each HCF. We include the 
cases of (1) 17 HCFs (blue curve), and (2) 54 HCFs (red 
curve).
(a) Map of KwaZulu-Natal, indicating (with black crosses) the  location of the 17 health care facilities (HCFs) that have been  designated for ART rollout by the South African Govern- ment, and the spatial distribution of communities distin- guished by the number of PLWHA (by both size and color) Figure 1
(a) Map of KwaZulu-Natal, indicating (with black crosses) the 
location of the 17 health care facilities (HCFs) that have been 
designated for ART rollout by the South African Govern-
ment, and the spatial distribution of communities distin-
guished by the number of PLWHA (by both size and color). 
Durban is the capital city of the province and has more 
PLWHA than any other community, followed by the cities of 
Pietermaritzburg and Newcastle; these urban cities are rep-
resented by the large red unfilled diamonds. We exclude 
these three large urban cities and analyze treatment accessi-
bility only for rural communities. (b) Two-dimensional form 
of a simple function that describes accessibility to ART 
(assuming that the catchment area has a radius of 10 km). 
The mathematical form of this accessibility measure is known 
as a Gaussian, f(d) = exp (-kd2). The catchment area radius is 
defined as the distance where treatment access is reduced to 
1% relative to access at a given HCF; the catchment radius is 
used to calculate the access-scaling parameter k in the treat-
ment-accessibility function.
(a)
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able) to travel 50 km to receive ART, still only ~50%
(~52000/110000) of the PLWHA in rural KwaZulu-Natal
would be able to access treatment (Figure 2).
The number of HCFs that are utilized (17 versus 54) obvi-
ously also affects treatment accessibility (Figure 2). How-
ever, surprisingly, our calculations show that increasing
the number of available HCFs for ART distribution ~
threefold does not lead to a threefold increase in treat-
ment accessibility in rural KwaZulu-Natal (Figure 2). An
increase in treatment accessibility is not proportionate to
an increase in HCFs because of HCF locality. Many of the
17 HCFs that are currently utilized for ART distribution
are located in or near urban areas, and hence they serve a
relatively large number of PLWHA. Many of the addi-
tional 37 HCFs that could be utilized are in rural areas and
would serve a fairly low number of PLWHA, as rural com-
munities are widely spaced. Therefore, as we have shown,
the impact of an additional 37 HCFs on treatment acces-
sibility in rural KwaZulu-Natal would be less substantial
than might be expected.
Discussion and conclusion
Our results show that many PLWHA in rural KwaZulu-
Natal are unlikely to have access to ART. We highly recom-
mend that studies collect data on the distance that
PLWHA are able (or willing) to travel for treatment. This
will commence the facilitation of discussion and deci-
sions on ART allocation, and would help focus goals
towards enabling PLWHA to access ART. A mobile clinic
that travels between remote communities to take health-
care workers and resources to locations of demand in
Nigeria is an initiative that other regions could imple-
ment. If new HCFs were to be constructed to increase ART
access and other basic health care needs, optimization
techniques could be used to determine the most appropri-
ate location [20]. Following initial consultation and drug
disbursement, frequent monitoring must also be sus-
tained long-term. Given the limited experience with large-
scale ART programs in rural resource-constrained coun-
tries, learning from newly implemented programs is
essential in informing the direction and priorities that will
ensure long-term sustainability, quality, and success.
Although there is no single solution regarding how best to
introduce ART into resource-constrained settings, obvi-
ously more drugs, healthcare personnel and HCFs are
needed in these countries [1,3], particularly in rural areas.
Innovative programs are urgently needed to remove the
substantial barriers for PLWHA in rural regions (such as
long travel distances, shortage of trained health profes-
sionals, lack of transportation and community stigma
toward PLWHA). Addressing the critical need for ade-
quate care for PLWHA in rural areas requires immediate
investment in rural areas in basic infrastructure, particu-
larly human resources and rural primary health facilities.
Our results have shown that there is a great length to go
before we will be able to reach many PLWHA in rural
areas in Africa, and specifically in KwaZulu-Natal.
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